Advancing to the Next Level of Care With Bispecific Antibodies in R/R FL and R/R DLBCL +++

Optimizing Outcomes With Radiopharmaceuticals in mCRPC Care: From Evidence to Execution CME Optimizing Outcomes With Radiopharmaceuticals in mCRPC Care: From Evidence to Execution Authors: Joe O’Sullivan, PhD, MD, BAO, BCH, FRCR, FFRRCSI, FRCPI; Irene Burger, MD; Elena Castro, MD, PhD; Bertrand Tombal, MD, PhD https://www.medscape.org/viewarticle/1003032?sso=true&impID=7873130&uac=148436CN&src=wnl_tpal_251113_mscpedu Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC CME / ABIM MOC Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC Authors: Alicia K. Morgans, MD, MPH, FASCO; Christian Gratzke, MD; Fred Saad, MD, FRCS, FCAHS; Tony Collier, BEM https://www.medscape.org/viewarticle/advancing-personalized-care-prostate-cancer-patient-centered-2025a1000uyb?page=1&sso=true&impID=7873130&uac=148436CN&src=wnl_tpal_251113_mscpedu Advancing to the Next Level of Care With Bispecific Antibodies in R/R FL and R/R DLBCL CME / ABIM MOC / CE Advancing to the Next Level of Care With Bispecific Antibodies in R/R FL and R/R DLBCL Authors: Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO; Amy Goodrich, RN, MSN, CRNP-AC; Ryan Haumschild, PharmD, MS, MBA, CPEL; Caitlin Murphy, DNP, APRN, FNP-BC, AOCNP https://www.medscape.org/viewarticle/advancing-next-level-care-bispecific-antibodies-r-r-fl-and-r-2025a1000v4k?page=1&sso=true&impID=7873130&uac=148436CN&src=wnl_tpal_251113_mscpedu